12-24 Hours
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
0 People recently viewed this
Zenocin
Navana Pharmaceuticals Ltd.
Generic: Ozenoxacin topical
Medicine Overview of Zenocin 1% w/w Cream
বাংলা
English
Indication
Impetigo
Administration
Topical use only
Apply a thin layer topically to affected area
Wash hands prior to application if the hands are not the area for treatment
Do not swallow ozenoxacin or use it in the eyes, mouth, lips, inside the nose, or inside the female genital area
Treated area may be covered by a sterile bandage or gauze dressing
Adult Dose
Impetigo
Indicated for impetigo due to Staphylococcus aureus (S. aureus) or Streptococcus pyogenes (S. pyogenes) in adults and children aged >2 months
Apply a thin layer topically to affected area q12hr for 5 days
Affected area may be up to 100 cm² in adults and adolescents aged >12 years
Child Dose
Impetigo
Indicated for impetigo due to Staphylococcus aureus (S. aureus) or Streptococcus pyogenes (S. pyogenes) in adult and children ?2 months
See also Administration
12 years
Apply a thin layer topically to affected area q12hr for 5 days
Affected area may be up to 100 cm² in adults and adolescents aged >12 years
Mode of Action
Quinolone antimicrobial drug; it inhibits bacterial DNA replication enzymes, DNA gyrase A, and topoisomerase IV
Ozenoxacin has been shown to be bactericidal against S. aureus (including methicillin-resistant isolates) and S. pyogenes organisms
Precaution
Prolonged use of ozenoxacin may result in overgrowth of nonsusceptible bacteria and fungi; if such infections occur, discontinue use and institute alternative therapy
Antagonism interactions with ozenoxacin were observed with ciprofloxacin against S. aureus
Side Effect
Frequency Not Defined
Rosacea
Seborrheic dermatitis
Pregnancy Category Note
Pregnancy Data are not available on the use of ozenoxacin in pregnant women Systemic absorption of ozenoxacin in humans is negligible following topical administration of ozenoxacin; owing to the negligible systemic exposure, it is not expected that maternal use of ozenoxacin will result in fetal exposure to the drug Lactation No data are available regarding the presence of ozenoxacin in human milk, and the effects of ozenoxacin on the breastfed infant or on milk production Breastfeeding is not expected to result in exposure of the child to ozenoxacin due to the negligible systemic absorption of ozenoxacin in humans following topical...
... Show moreব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
